Roche is a relative latecomer in the chase to block a protein called KRAS G12C to treat lung cancer, but the pharmaceutical company has been testing its contender head-to-head against

This week, the FDA granted breakthrough device designation to Aurenar‘s V-Link system, a non-invasive nerve stimulation device designed to treat cerebral vasospasm. Vasospasm is one of the most dangerous complications

Color, a virtual cancer clinic, announced Tuesday that it has expanded its Expert Medical Opinion services to include a new peer-to-peer program. San Francisco-based Color serves employers, health plans, unions

In March, a major cyberattack hit Stryker, one of the world’s largest medical technology companies. The group that claimed responsibility, Handala, is linked to Iran, and the hackers were explicit

This week, Neurovalens‘ Modius Spero became the first neuromodulation device to earn FDA approval to treat PTSD. Veterans, who face disproportionately high PTSD rates, will be the first to gain

Evernorth, the health services division of The Cigna Group, launched a new AI-powered program for specialty pharmacy on Thursday called Pharmacy Forward. The program is backed by a $100 million

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to exploring the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Cathleen Brown, medical

Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work.  “Claude

It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals with a $1.5 billion agreement to buy the neuromuscular business

For decades, cameras in hospital corridors were a valuable tool for capturing forensic evidence, though they were not yet the proactive security asset we see today. That model is changing